Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weir, G. C.
Right arrow Articles by Martin, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weir, G. C.
Right arrow Articles by Martin, D. B.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 25, Issue 4 275-282, Copyright © 1976 by American Diabetes Association


ARTICLES

Glucagon secretion from the perfused pancreas of streptozotocin-treated rats

GC Weir, SD Knowlton, RF Atkins, KX McKennan and DB Martin

One hour following intravenous streptozotocin, rat pancreases were perfused in situ, and , in contrast to saline-injected controls a marked decrease of insulin secretion was observed. In these streptozotocin-treated animals, baseline glucagon secretion was enhanced when the perfusate glucose concentration was either 80 mg./100 ml. or 300 mg./100 ml. In addition there was hypersecretion of glucagon in response to arginine. Exogenous insulin (20,000 muU./ml.) could suppress glucagon secretion when endogenous secretion was plentiful. Baseline and arginine-stimulated glucagon secretion of the streptozotocin treated animals was not suppressed by large amounts of glucose and insulin to the degree seen in control animals. The glucagon rise in response to an abrupt fall of glucose from 80 mg./100 ml. to 25 mg./100 ml. was not significantly higher in the control group than in the streptozotocin group. The results seen with epinephrine were in sharp contrast to those found with arginine. Epinephrine-stimulated glucagon secretion was not enhanced in the streptozotocin group. In addition, epinephrine-induced secretion could be suppressed by exogenous insulin in both the control and streptozotocin groups. The differences may be secondary to differences of endogenous insulin secretion. The present results are compatible with the hypothesis that local insulin secretion can exert a significant suppressive effect upon the alpha cell and that the inhibition of glucagon secretion by glucose is partially mediated by this mechanism. Furthermore, anomalous local insulin secretion may contribute to the abnormal glucagon secretion of diabetes mellitus.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
R. D. Wideman, S. D. Covey, G. C. Webb, D. J. Drucker, and T. J. Kieffer
A Switch From Prohormone Convertase (PC)-2 to PC1/3 Expression in Transplanted {alpha}-Cells Is Accompanied by Differential Processing of Proglucagon and Improved Glucose Homeostasis in Mice
Diabetes, November 1, 2007; 56(11): 2744 - 2752.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Gromada, I. Franklin, and C. B. Wollheim
{alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Endocr. Rev., February 1, 2007; 28(1): 84 - 116.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Shiota, J. V. Rocheleau, M. Shiota, D. W. Piston, and M. A. Magnuson
Impaired glucagon secretory responses in mice lacking the type 1 sulfonylurea receptor
Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E570 - E577.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. A. Ravier and G. A. Rutter
Glucose or Insulin, but not Zinc Ions, Inhibit Glucagon Secretion From Mouse Pancreatic {alpha}-Cells
Diabetes, June 1, 2005; 54(6): 1789 - 1797.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
I. Franklin, J. Gromada, A. Gjinovci, S. Theander, and C. B. Wollheim
{beta}-Cell Secretory Products Activate {alpha}-Cell ATP-Dependent Potassium Channels to Inhibit Glucagon Release
Diabetes, June 1, 2005; 54(6): 1808 - 1815.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. M. Hope, P. O. T. Tran, H. Zhou, E. Oseid, E. Leroy, and R. P. Robertson
Regulation of {alpha}-Cell Function by the {beta}-Cell in Isolated Human and Rat Islets Deprived of Glucose: the "Switch-off" Hypothesis
Diabetes, June 1, 2004; 53(6): 1488 - 1495.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Omer, V. F. Duvivier-Kali, W. Aschenbach, V. Tchipashvili, L. J. Goodyear, and G. C. Weir
Exercise Induces Hypoglycemia in Rats With Islet Transplantation
Diabetes, February 1, 2004; 53(2): 360 - 365.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. Paris, C. Bernard-Kargar, M.-F. Berthault, L. Bouwens, and A. Ktorza
Specific and Combined Effects of Insulin and Glucose on Functional Pancreatic {beta}-Cell Mass in Vivo in Adult Rats
Endocrinology, June 1, 2003; 144(6): 2717 - 2727.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Banarer, V. P. McGregor, and P. E. Cryer
Intraislet Hyperinsulinemia Prevents the Glucagon Response to Hypoglycemia Despite an Intact Autonomic Response
Diabetes, April 1, 2002; 51(4): 958 - 965.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y.-J. Liu, Y. Nakagawa, and T. Ohzeki
Gene Expression of 11ß-Hydroxysteroid Dehydrogenase Type 1 and Type 2 in the Kidneys of Insulin-Dependent Diabetic Rats
Hypertension, March 1, 1998; 31(3): 885 - 889.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1976 by the American Diabetes Association.